GlassScriptPhysician profile
Amina Hanif
NPI 1740603364
$647.00
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $293 · 2023: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $161.86 | 2021-2022 | |
| Abbvie INC. | $161.49 | 2021-2023 | |
| Almatica Pharma LLC | $71.91 | 2022-2023 | Loreev Xr, Sertraline Hcl |
| Otsuka America Pharmaceutical, INC. | $70.38 | 2021-2022 | |
| Bausch Health US, LLC | $66.06 | 2022-2023 | Wellbutrin |
| Sunovion Pharmaceuticals INC. | $44.38 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.81 | 2021-2022 | |
| Neos Therapeutics, LP | $15.94 | 2023 | Adzenys Xr-Odt |
| Janssen Pharmaceuticals, INC | $15.67 | 2021 | |
| Lundbeck LLC | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amina Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.